Rare diseases
Investigational molecules
Locations
147 conditions with trials, the busiest first
548 trials across Europe, recruiting first
Study on Adding OSU6162 to Treatment for Patients with Depression Resistant to SSRI/SNRI Medications
SwedenA Study of OSU6162 in Adults with Bipolar Depression to Evaluate Safety and Effectiveness
SwedenStudy on Ketamine and Midazolam for Treating Obsessive-Compulsive Disorder in Adults
AustriaStudy on the Effects of Cariprazine on Cognitive Function in Schizophrenia Patients Needing Antipsychotic Treatment Adjustment
AustriaStudy on Valsartan for Slowing Aortic Root Dilatation in Children and Young Adults with Marfan Syndrome and Related Conditions
PolandPhase 3 Randomized Double‑Blind Study of Pitolisant versus Placebo for Safety and Efficacy in Adults with Idiopathic Hypersomnia
BelgiumEvaluation of Trazodone Hydrochloride for Improving Emotional Blunting in Patients with Major Depressive Disorder
BulgariaSafety and efficacy of NFL-102 versus placebo for adults with tobacco dependence (Phase I/II)
FrancePhase 3 Double‑Blind Relapse Prevention Trial of Trospium Chloride and Xanomeline Tartrate (KarXT) in Adults with Schizophrenia
DenmarkEfficacy and Safety of Trontinemab with [18F]MK-6240 in Cognitively Unimpaired Individuals at Risk for Alzheimer’s Disease
DenmarkEffect of Prucalopride Added to Sertraline Compared with Placebo on Mood and Memory in Women with Major Depressive Disorder
DenmarkEffect of Methylphenidate versus Placebo on Attachment‑Related Learning in Children with Attention‑Deficit/Hyperactivity Disorder (ADHD)
BelgiumThe therapies tested most often in Psychiatric disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
